Lv4
580 积分 2022-03-24 加入
IL-17, IL-6 and IFN-γ in systemic sclerosis patients
5天前
已完结
Targeting interferons as a strategy for systemic sclerosis treatment
5天前
已完结
Employment outcomes in systemic sclerosis
5天前
已完结
Domain reporting in systemic sclerosis-related Raynaud's phenomenon: An OMERACT scoping review
5个月前
已完结
Domain reporting in Systemic Sclerosis-Related Digital Ulcers: An OMERACT Scoping Review
5个月前
已完结
Re-envisioning clinical trial design in systemic sclerosis
7个月前
已完结
Clinical Trial Design Issues in Systemic Sclerosis: an Update
7个月前
已完结
Th17 peripheral cells are increased in diffuse cutaneous systemic sclerosis compared with limited illness: a cross-sectional study
8个月前
已完结
皖公网安备34019202002308
